Cyclodinone tablets p / o No. 15×2

Name:
Cyclodynon tab. p / captive ob. in bl. in pack. No. 15×2
Description:
Round biconvex film-coated tablets, greenish-blue color with a matte surface The main active ingredient of the common fruit extract Form of production Film-coated tablets. 15 tablets in a blister of aluminum foil and PVC / PVDC films. 2 or 4 blisters are placed together with instructions for use in a cardboard pack. Special instructionsIndication for patients with diabetes mellitus: carbohydrates included in 1 tablet of the drug are less than 0.03 “bread units” (XE). In the presence of malignant estrogen-dependent tumors at the present time or history, diseases of the pituitary gland in history – a doctor’s consultation is required. Consideration should be given to the possibility of masking the clinical manifestations of a pituitary tumor that secretes prolactin while taking the drug. List of conditions requiring medical consultation: if you feel tension and swelling of the mammary glands and / or weakness, depression, as well as menstrual irregularities, you should consult a doctor for additional examination. In order to monitor the effectiveness of the treatment, a monthly consultation with a doctor is recommended. Pharmacological action The components of the drug have a normalizing effect on the concentration of sex hormones. The main active ingredient of the drug is the common prutnyak. Dopaminergic effects of the drug, causing a decrease in prolactin production, eliminate hyperprolactinemia. An increased concentration of prolactin disrupts the secretion of gonadotropins, as a result of which there may be violations of the maturation of follicles, ovulation and the formation of a corpus luteum, which further leads to an imbalance between estradiol and progesterone and can cause menstrual irregularities, as well as mastodynia. Unlike estrogens and other hormones, prolactin also has a direct stimulating effect on the proliferative processes in the mammary glands, enhancing the formation of connective tissue and causing the expansion of the milk ducts. A decrease in the concentration of prolactin leads to the reverse development of pathological processes in the mammary glands and relieves pain. The rhythmic production and normalization of the ratio of gonadotropic hormones leads to the normalization of the second phase of the menstrual cycle. Indications for use Menstrual disorders, premenstrual syndrome, mastodynia. Before starting the use of the drug, you should consult your doctor. Dosage and administration Take 1 tablet orally 1 time per day in the morning, without chewing, with a sufficient amount of 100-200 ml of water. The duration of treatment is at least 3 months (without a break during menstruation). The use of the drug for more than 3 months should be discussed with the doctor. If the symptoms of the disease persist during the use of the drug, you should consult a doctor. If complaints reappear after completion of treatment, it is necessary to consult a doctor. There are no data on recommended doses for renal or hepatic insufficiency. The drug should not be used to treat children and adolescents under the age of 18 years. Use during pregnancy and lactation The drug is not used during pregnancy and during breastfeeding. With an increase in the regularity of the menstrual cycle while taking the drug, the likelihood of pregnancy increases. When pregnancy occurs, the drug should be discontinued. Precautions Precautions should be observed if patients have estrogen-dependent malignancies and a history of pituitary disease. Before you start using the drug, you should consult with your doctor. Interaction with other drugs Possible mutual decrease in effectiveness while taking dopamine receptor antagonists, as well as interaction with dopamine receptor agonists, estrogens and antiestrogen. If you are taking these drugs, you should consult your doctor before you start taking Cyclodinone®. Interaction with other drugs is currently unknown. ContraindicationsIndividual hypersensitivity to the components of the drug, lactose intolerance, lactase deficiency, glucose-galactose malabsorption (due to the content of lactose in the drug), breast cancer, pituitary tumors, age up to 18 years (there is no data on the efficacy and safety of the drug in this age group ); pregnancy and breastfeeding period. Composition Active ingredient: Prutnyak* fruit dry extract (7-11: 1, extractant – ethanol 70% by volume) – 4.00 mg Excipients: povidone K 30, colloidal silicon dioxide, potato starch, lactose monohydrate, microcrystalline cellulose, magnesium stearate, talc, titanium dioxide (E 171), iron dye yellow oxide (E 172), aluminum indigo carmine varnish (E 132), macrogol 6000, ammonium methacrylate copolymer (type A) * Latin name – Vitex agnus-castus L. Overdose Cases overdoses are not registered. In case of an overdose, it is possible to increase the severity of dose-dependent side effects. Treatment is symptomatic. Side effects Possible severe allergic reactions with swelling of the face, shortness of breath and dysphagia. Allergic reactions from the skin (rash, urticaria), gastrointestinal disorders (pain in the epigastric region, nausea), headache, dizziness, acne, menstrual disorders may occur. The frequency of adverse reactions is unknown, ie. cannot be estimated from the available data. If the adverse reactions described above or other adverse reactions that are not indicated in the instructions appear, the drug should be stopped and consult a doctor. Storage conditionsStore in the original packaging, at a temperature not exceeding 25°C. Keep out of the reach of children! Buy Cyclodinone tablets p/o No. 15×2 Price for Cyclodinone tablets p/o No. 15×2